- Home
- Publications
- Publication Search
- Publication Details
Title
Oligonucleotide-Based Therapies for Inflammatory Bowel Disease
Authors
Keywords
-
Journal
BIODRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-08
DOI
10.1007/s40259-018-0286-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease
- (2018) Brian G. Feagan et al. GASTROENTEROLOGY
- Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice
- (2018) Roberta Izzo et al. INFLAMMATORY BOWEL DISEASES
- Current Advances in Aptamers for Cancer Diagnosis and Therapy
- (2018) Shin-ichiro Hori et al. Cancers
- Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice
- (2017) Vanessa Popp et al. GASTROENTEROLOGY
- Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
- (2017) Zhenjian Zhuo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Current and emerging therapeutic targets for IBD
- (2017) Markus F. Neurath Nature Reviews Gastroenterology & Hepatology
- Crystal structure of an RNA-cleaving DNAzyme
- (2017) Hehua Liu et al. Nature Communications
- Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial
- (2016) Iris Dotan et al. DIGESTIVE DISEASES AND SCIENCES
- Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn’s Disease Patients with Active Mucosal Lesions
- (2016) Kenji Suzuki et al. Journal of Crohns & Colitis
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery
- (2016) Walt F. Lima et al. NUCLEIC ACIDS RESEARCH
- Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
- (2016) Kenji Suzuki et al. PLoS One
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
- (2015) Giovanni Monteleone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series
- (2015) Thomas Greuter et al. United European Gastroenterology Journal
- Development of Drugs to Target Interactions Between Leukocytes and Endothelial Cells and Treatment Algorithms for Inflammatory Bowel Diseases
- (2014) Silvio Danese et al. GASTROENTEROLOGY
- GATA-3 Function in Innate and Adaptive Immunity
- (2014) Irma Tindemans et al. IMMUNITY
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease
- (2012) F. Zorzi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Further developments with antisense treatment for myasthenia gravis
- (2012) Jon Sussman et al. Annals of the New York Academy of Sciences
- Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity
- (2012) Eugen Musch et al. INFLAMMATORY BOWEL DISEASES
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
- (2012) Giovanni Monteleone et al. MOLECULAR THERAPY
- Transcript levels of Toll-Like receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis
- (2011) Fausto Sánchez-Muñoz et al. BMC GASTROENTEROLOGY
- An Overview of Sugar-Modified Oligonucleotides for Antisense Therapeutics
- (2011) Thazha P. Prakash CHEMISTRY & BIODIVERSITY
- Regulation of Homeostasis and Inflammation in the Intestine
- (2011) Thomas T. MacDonald et al. GASTROENTEROLOGY
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells
- (2010) C. Hofmann et al. GUT
- Homing of immune cells: Role in homeostasis and intestinal inflammation
- (2010) Ailsa L. Hart et al. INFLAMMATORY BOWEL DISEASES
- Long-term complications, extraintestinal manifestations, and mortality in adult Crohnʼs disease in population-based cohorts
- (2010) Laurent Peyrin-Biroulet et al. INFLAMMATORY BOWEL DISEASES
- Intestinal fibrosis in IBD—a dynamic, multifactorial process
- (2009) Florian Rieder et al. Nature Reviews Gastroenterology & Hepatology
- Transcriptional Regulation ofGata3in T Helper Cells by the Integrated Activities of Transcription Factors Downstream of the Interleukin-4 Receptor and T Cell Receptor
- (2008) Eyal J. Scheinman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intestinal fibrosis in inflammatory bowel disease — Current knowledge and future perspectives
- (2008) Florian Rieder et al. Journal of Crohns & Colitis
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started